Status:
UNKNOWN
Cessation of Dialysis Treatment in Reinbek and Geesthacht
Lead Sponsor:
University of Luebeck
Conditions:
Complication of Renal Dialysis
Long-Term Disorder of Dialysis
Eligibility:
All Genders
18-99 years
Brief Summary
Currently, approximately 80.000 patients with end stage renal disease (ESRD) in Germany undergo chronic renal replacement therapy, either as hemodialysis or peritonealdialysis. Since the nationwide re...
Eligibility Criteria
Inclusion
- Patients with end stage renal disease and hemodialyis or peritonealdialysis
- Renal replacement therapy performed in our centers Reinbek or Geesthacht
- at least 4 weeks of dialysis treatment in any of our two treatment sites
Exclusion
- dialysis treatment period in our centers shorten than 4 weeks
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03820765
Start Date
January 1 2016
End Date
January 31 2020
Last Update
January 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology Center Reinbek and Geesthacht
Reinbek, Germany, 21465